CF PharmTech, Inc. (02652) Announces Share Repurchase and Updates on Issued Shares

Bulletin Express
Yesterday

On 9 February 2026, CF PharmTech, Inc. repurchased 1,500 H shares on the Hong Kong Stock Exchange at a highest price of HKD 35.12 and a lowest price of HKD 35.08 per share. The total repurchase amounted to HKD 52,650. These repurchased shares are held as treasury shares.

Following this repurchase, the number of issued shares (excluding treasury shares) stood at 302,010,086, while the total number of shares remained at 302,223,586. The total count of treasury shares reached 213,500. The repurchase was conducted under a mandate approved on 16 December 2025 that authorized up to 30,222,358 shares to be repurchased, representing 0.0706% of the issuer’s total number of issued shares (excluding treasury shares) as at the date of the mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10